Evidence map›Paper›PMID 35614923›Full record

ArticleFrontiers in neurology2022

Human Encephalitis Complicated With Ocular Symptoms Associated With Pseudorabies Virus Infection: A Case Report.

Liu Yue, Li Yi, Tong Fei, Tian MengWu, Li Man, Wang LiQing, Zou YueLi, Duan JiaLiang, Bu Hui, He JunYing

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Identifying potential monkeypox virus inhibitors: anFrontiers in cellular and infection microbiology · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Liu YueDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Li YiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Tong FeiDepartment of Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Tian MengWuDepartment of Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Li ManDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Wang LiQingDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zou YueLiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Duan JiaLiangDepartment of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Bu HuiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
He JunYingDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Medical University · CNSecond Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudorabies virus (PRV) is an alpha herpesvirus found in many wild and domestic animals, and causes neurological diseases in humans. Several cases of PRV-induced human encephalitis accompanied with severe visual impairment have been reported. There is currently no effective treatment for severe visual impairment caused by PRV. We report a case of PRV encephalitis with severe visual impairment. The diagnosis and treatment experience of this patient is summarized to improve the awareness of clinicians. We present a 42-year-old man with PRV infection who was admitted due to intermittent fever for 5 days and unconsciousness for 1 day. He subsequently developed severe visual impairment during hospital stay. Empirical antiviral treatment with ganciclovir and sodium foscarnet was started on the day of admission and continued for > 50 days, which had significant treatment effect. Eye complications caused by PRV infection have been frequently reported in patients with PRV encephalitis. In this patient, based on the patient's condition, antiviral therapy was initiated on admission day, and according to the results of the next-generation sequencing of the cerebrospinal fluid, the duration of antiviral therapy was prolonged, which improved treatment efficacy and alleviated neurological symptoms and eye vision damage. To the best of our knowledge, this is the first report that describes partial restoration of acute vision loss associated with PRV infection after aggressive treatment. Our experience suggests that although prompt treatment cannot prevent the acute vision loss associated with PRV infection, timely anti-viral and anti-inflammatory treatment can alleviate ocular complications.

Indexed as

antiviral therapycase reportnext-generation sequencingsevere visual impairmentviral encephalitis

Identifiers

PMID35614923
PMCPMC9125146
OpenAlexW4229450459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.